<?xml version="1.0" encoding="UTF-8"?>
<ref id="B104">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jeffers</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Tusell</surname>
    <given-names>S. M.</given-names>
   </name>
   <name>
    <surname>Gillim-Ross</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hemmila</surname>
    <given-names>E. M.</given-names>
   </name>
   <name>
    <surname>Achenbach</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Babcock</surname>
    <given-names>G. J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2004</year>). 
  <article-title>CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.</article-title>
  <source>
   <italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
  </source>
  <volume>101</volume>
  <fpage>15748</fpage>â€“
  <lpage>15753</lpage>. 
  <pub-id pub-id-type="doi">10.1073/pnas.0403812101</pub-id>
  <?supplied-pmid 15496474?>
  <pub-id pub-id-type="pmid">15496474</pub-id>
 </mixed-citation>
</ref>
